Nitric oxide synthase-containing neurons in the human hypothalamus: Reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics

Neuroscience

Volumn 83, Issue 3, 1998, Pages 867-875

  Bernstein, H G ^a   Stanarius, A ^a   Baumann, B ^a   Henning, H ^a   Krell, D ^a   Danos, P ^a   Falkai, P ^b   Bogerts, B ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Depression; Human hypothalamus; Immunohistochemistry; Nitric oxide synthase; Schizophrenia

Indexed keywords

NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; BEHAVIOR; CELL COUNT; CELL DENSITY; CLINICAL ARTICLE; DEPRESSION; FEMALE; HORMONE RELEASE; HUMAN; HYPOTHALAMUS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCHIZOPHRENIA; THALAMUS MIDLINE NUCLEUS;

ADULT; AGED; CELL COUNT; DEPRESSION; FEMALE; HUMANS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEURONS; NITRIC OXIDE SYNTHASE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; REFERENCE VALUES; SCHIZOPHRENIA;

EID: 0032484549     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00461-2     Document Type: Article

References (55)

1. 1. Aguila M. C. (1994) Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase. Proc. natn. Acad. Sci. U.S.A. 91, 782-786.
2. 2. Akbarian S., Bunney W. E. Jr, Potkin S. G., Wigal S. B., Hagmann J. O., Sandman C. A. and Jones E. G. (1993) Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Archs gen. Psychiat. 50, 169-177.
3. 3. Alonso J. R., Sanchez F., Arevalo R., Carretero J., Vazquez R. and Aijon J. (1992) Partial coexistence of NADPH diaphorase and somatostatin in the rat hypothalamic paraventricular nucleus. Neurosci. Lett. 148, 101-104.
4. 4. Amir S. (1995) Nitric oxide signaling in the hypothalamus. In Nitric Oxide in the Nervous System (ed. Vincent S. R.), pp. 151-162. Academic, San Diego.
5. 5. Bachneff S. A. (1996) Regional cerebral blood flow in schizophrenia and the local circuit neurons hypothesis. Schizophrenia Bull. 22, 163-182.
6. 6. Bahr M. (1997) How should brain nuclei be delineated? Consequences for developmental mechanisms and for correlations of area size, neuron numbers and function of brain nuclei. Trends Neurosci. 20, 58-62.
7. 7. Bernstein H.-G., Henning H., Seliger N., Baumann B. and Bogerts B. (1996) Remarkable beta-endorphinergic innervation of human cerebral cortex as revealed by immunohistochemistry. Neurosci. Lett. 214, 1-4.
8. 8. Bhat G. K., Mahesh V. B., Lamar C. A., Ping L., Aguan K. and Brann D. W. (1995) Histochemical localization of nitric oxide neurons in the hypothalamus-association with gonadotropin-releasing hormone neurons and colocalization with N-methyl-D-aspartate receptors. Neuroendocrinology 62, 187-197.
9. 9. Bhat G. K., Mahesh V. B., Aguan K. and Brann D. W. (1996) Evidence that brain nitric oxide synthase is the major nitric oxide synthase in the hypothalamus of the adult female rat and that nitric oxide potently regulates cGMP levels. Neuroendocrinology 64, 93-102.
10. 10. Bredt D. S., Hwang P. M. and Snyder S. H. (1990) Localization of nitric oxide synthase indicating a neural role. Nature 347, 768-770.
11. 11. Buwalda B., Nyakas C., Gast J., Luiten P. G. and Schmidt H. H. H. W. (1995) Aldehyde fixation differentially affects distribution of diaphorase activity but not nitric oxide synthase immunoreactivity in rat brain. Brain Res. Bull. 28, 467-479.
12. 12. Calka J. and Block C. H. (1993) Relationship of vasopressin with NADPH diaphorase in the hypothalamo-neurohypophysial system. Brain Res. Bull. 32, 207-210.
13. 13. Calka J., Wolf G. and Brosz M. (1994) Ultrastructural demonstration of NADPH diaphorase histochemical activity in the suprapotic nucleus of normal and dehydrated rats. Brain Res. Bull. 34, 301-308.
14. 14. Chapleau M. W. and Aboud F. M. (1994) Modulation of baroreceptor activty by ionic and paracrine mechanisms: overview. Braz. J. med. biol. Res. 27, 1001-1015.
15. 15. Coggeshall R. E. and Lekan H. A. (1996) Methods for determining numbers of cells and synapses: A case for more uniform standards of review. J. comp. Neurol. 364, 6-15.
16. 16. Corasaniti M. T., Paoletti A. M., Palma P., Granato T., Navarra M. and Nistico G. (1995) Systemic administration of pramiracetam increases nitric oxide synthase activity in the cerebral cortex of the rat. Funct. Neurol. 10, 151-155.
17. 17. Costa A., Trainer B., Besser M. and Grossmann A. (1993) Nitric oxide modulates the release of corticotropin-releasing hormone from rat hypophysis. Brain Res. 605, 187-192.
18. 18. Costa A., Poma A., Navarra P., Forsling M. L. and Grossman A. (1996) Gaseous transmitters as new agents in neuroendocrine regulation. J. Endocr. 149, 199-207.
19. 19. Egberongbe Y. I., Gentleman S. M., Falkai P., Bogerts B., Polak J. M. and Roberts G. W. (1994) The distribution of nitric oxide synthase immunoreactivity in the human brain. Neuroscience 59, 561-578.
20. 20. Gentleman S. M., Leclercq P., Von Bussmann K. A., Garey L. J. and Royston M. C. (1995) Differential distribution of nitric oxide synthase neurons in the cerebral cortex of schizophrenics. Schizophrenia Res. 15, 28.
21. 21. Gonzalez-Hernandez T., Angeles Perez de La Cruz M. and Mantolan-Sarmiento B. (1996) Histochemical and immunohistochemical detection of neurons that produce nitric oxide: effect of different fixative parameters and immunoreacticvity against non-neuronal NOS antisera. J. Histochem. Cytochem. 44, 1399-1413.
22. 22. Harvey B. H. (1996) Affective disorders and nitric oxide - a role in pathways to relapse and refractoriness. Human Psychopharmac.-clin. Exper. 11, 309-319.
23. 23. Hökfelt T., Johannson D. and Goldstein M. (1984) Chemical anatomy of the brain. Science 225, 1326-1334.
24. 24. Holsboer F. and Barden N. (1996) Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Rev. 17, 187-205.
25. 25. Hope B. T., Michael G. J., Knigge K. M. and Vincent S. R. (1991) Neuronal NADPH diaphorase is a nitric oxide synthase. Proc. natn. Acad. Sci. U.S.A. 88, 2811-2814.
26. 26. Hu J. G., Lee J. H. and Elfakahany E. E. (1994) Inhibition of neuronal nitric-oxide synthase by antipsychotic drugs. Brain Res. 114, 161-166.
27. 27. Karson C. N., Griffin W. S. T., Mrak R. E., Husain M., Dawson T. M., Snyder S. H., Moore N. C. and Sturner W. Q. (1996) Nitric oxide synthase (NOS) in schizophrenia-increases in cerebellar vermis. Molec. chem. Neuropath. 27, 275-284.
28. 28. Krukoff T. A. and Khalili P. (1997) Stress-induced activation of nitric oxide-producing neurons in the rat brain. J. comp. Neurol. 377, 509-519.
29. 29. Kugler P. and Drenckhahn D. (1996) Astrocytes and Bergmann glia as an important site of nitric oxide synthase I. Glia 16, 165-173.
30. 30. Lee S., Barbanel G. and Rivier C. (1995) Systemic endotoxin increases steady-state gene expression of hypothalamic nitric oxide synthase: comparison with corticotropin-releasing factor and vasopressin gene transcripts. Brain Res. 705, 136-148.
31. 31. Lesch A. and Bogerts B. (1984) The diencephalon in schizophrenia: evidence for reduced thickness of the periventricular grey matter. Eur. Archs psych. neurol. Sci. 234, 212-219.
32. 32. Mai J. K., Berger K. and Sofroniew M. V. (1993) Morphometric evaluation of neurophysin-immunoreactivity in the human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia. J. Hirnforsch. 34, 133-154.
33. 33. Mayhew T. M. (1992) A review of recent advances in stereology for quantifying neural structure. J. Neurocytol. 21, 313-328.
34. 34. Miller K. J. and Hoffman B. J. (1994) Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP. J. biol. Chem. 269, 27,351-27,356.
35. 35. Miyagawa A., Okamura H. and Ibata Y. (1994) Coexistence of oxytocin and NADPH-diaphorase in magnocellular neurons of the paraventricular and the suprapotic nuclei of rat hypothalamus. Neurosci. Lett. 171, 13-16.
36. 36. Moncada S., Palmer R. M. J. and Higgs E. A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmac. Rev. 43, 109-142.
37. 37. Montkowski A., Barden N., Wotjak C., Stec I., Ganster J., Meaney M., Engelmann M., Reul J. M., Landgraf R. and Holsboer F. (1995) Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J. Neuroendocr. 7, 841-845.
38. 38. Moretto M., Lopez F. J. and Negro-Vilar A. (1993) Nitric oxide regulates luteinizing hormone-releasing hormone secretion. Endocrinology 133, 2399-2402.
39. 39. Nieuwenhuys R., Voogd J. and Van Huijzen C. (1988) The Human Central Nervous System. A Synopsis and Atlas. 3rd revised edn. pp. 65-343, Springer-Verlag, Berlin, New York, Heidelberg.
40. 40. Purba J. S., Hoogendijk W. J. G., Hofman M. A. and Swaab D. F. (1996) Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Archs gen. Psychiat. 53, 137-143.
41. 41. Raadsheer F. C., Sluiter A. A., Ravid R., Tilders F. J. and Swaab D. F. (1993) Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin. Brain Res. 615, 50-62.
42. 42. Raadsheer F. C., Hoogendijk W. J. G., Stam F. C., Tilders F. J. and Swaab D. F. (1994) Increased number of corticotropin-releasing hormone neurons in the hypothalamic paraventricular nuclei of depressed patients. Neuro-endocrinology 60, 436-444.
43. 43. Raadsheer F. C., Van Heerikhuize J. J., Lucassen P. J., Hoogendijk W. J. G., Tilders F. J. and Swaab D. F. (1995) Increased corticotropin-releasing hormone (CRH) mRNA in paraventricular nuclei of depressed patients. Am. J. Psychiat. 152, 1372-1376.
44. 44. Rettori V., Belova N., Dees W., Nyberg C. L., Gimeno M. and McCann S. M. (1993) Role of nitric oxide in the control of luteinizing hormone-releasing hormone release in vivo and in vitro. Proc. natn. Acad. Sci. U.S.A. 90, 10,130-10,134.
45. 45. Rivier C. and Shen G. H. (1994) In the rat, endogenous nitric oxide modulates the response of the hypothalamo-pituitary-adrenal axis to interleukin-1β, vasopressin, and oxytocin. J. Neurosci. 14, 1985-1993.
46. 46. Sangruichi T. and Kowall N. W. (1991) NADPH diaphorase in the human hypothalamus. Neuroscience 40, 713-724.
47. 47. Siaud P., Mekaouche M., Ixart G., Balmebrezol M., Giralois L., Barnabel G. and Assenmacher I. (1994) A subpopulation of corticotropin-releasing hormone neurosecretory cells in the paraventricular nucleus of the hypothalamus also contain NADPH diaphorase. Neurosci. Lett. 170, 51-54.
48. 48. Sternberger L. A. (1979) Immunocytochemistry. Wiley, New York.
49. 49. Szabo C., Thiemermann C., Wu C. C., Perretti M. and Vane J. R. (1994) Attenuation of the induction of nitric oxide synthase by endogenous glucocorticids accounts for endotoxin tolerance in vivo. Proc. natn. Acad. Sci. U.S.A. 91, 271-275.
50. 50. Turnbull A. V. and Rivier C. (1996) Corticotropin-releasing factor, vasopressin, and prostaglandin mediate, and nitric oxide restrains, the hypothalamic-pituitary-adrenal response to acute local inflammation in the rat. Endocrinology 137, 455-463.
51. 51. Vincent S. R. and Kimura H. (1992) Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46, 755-784.
52. 52. West M. J. (1993) New stereological methods for counting neurons. Neurobiol. Aging 14, 275-285.
53. 53. Wiklund N. P., Cellek S., Leone A. M., Iversen H. H., Gustafson L. E., Brundin L., Furst V. W., Flock A. and Moncada S. (1997) Visualisation of nitric oxide released by nerve stimulation. J. Neurosci. Res. 47, 224-232.
54. 54. Wu W. and Scott D. E. (1993) Increased expression of nitric oxide synthase in hypothalamic neuronal regeneration. Expl Neurol. 121, 279-283.
55. 55. Yamada K., Emson P. and Hökfelt T. (1996) Immunohistochemical mapping of nitric oxide synthase in the rat hypothalamus and colocalization with neuropeptides. J. chem. Neuroanat. 10, 295-316.